About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Adjuvant Systemic Therapy for HER2 + Early Breast Cancer - Neratinib vs Placebo, Pertuzumab vs Placebo & T-DM1 vs Trastuzumab
By
Baltic and Eurasia Masterclass in Clinical Oncology
FEATURING
Alvydas Česas
By
Baltic and Eurasia Masterclass in Clinical Oncology
FEATURING
Alvydas Česas
334 views
August 1, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
London Breast Meeting
London Breast Meeting 2024
Wed, Sep 4, 2024
28:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …
Feat.
H. Rugo,
K. Jhaveri
17:39
Yale School of Medicine
2023 Menopause Update
Feat.
M. Minkin
14:16
Dana-Farber Cancer Institute
Year in Review: Breast Cancer
Feat.
P. Tarantino
17:20
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…
Feat.
P. Tarantino
09:19
Insights from 2023 SABCS
SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…
Feat.
K. Kalinsky
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
04:28
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …
Feat.
S. Tolaney
10:27
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuv…
Feat.
S. Tolaney,
H. Rugo
49:07
SABCS 2022 Conference Coverage
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
Feat.
J. O'Shaughnessy,
S. Tolaney,
S. Hurvitz,
H. Rugo
05:43
Total Health
Neoadjuvant Chemo for HR+ BC: Year in Review
Feat.
C. Ma
07:50
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…
Feat.
K. Kalinsky
22:34
Dana-Farber Cancer Institute
What's New in Breast Cancer?
Feat.
S. Tolaney
50:59
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"
Feat.
S. Tolaney,
H. Rugo
17:35
Insights from 2023 SABCS
SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…
Feat.
P. Tarantino
27:04
Fengting Yan
Cancer Screening Molecular Tools
30:46
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"
Feat.
S. Tolaney,
H. Rugo
07:18
V.K. Gadi
The Role of ctDNA as a Surveillance Approach in HR+/HER2- eBC
14:59
Insights from 2023 SABCS
SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial -…
Feat.
T. Mamounas
24:10
Keck School of Medicine of USC
CDK4/6 Inhibitors in Breast Cancer: 2024 Update
Feat.
R. O'Regan
21:37
Dana-Farber Cancer Institute
Standard Treatments for HR+/HER2- mBC in 2023
Feat.
S. Sammons
